On April 22, 2026, Outlook Therapeutics, Inc. announced a securities purchase agreement to raise $5 million by issuing 16,129,033 shares of common stock at $0.31 each, along with warrants for the same number of shares. A stockholder meeting is planned within 90 days for necessary approvals.